Randomized Trial of Iron Supplementation to Prevent Anemia in Very-low-birth-weight Infants

• Status: Completed
• Trial end date: 2012-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if iron supplementation in addition to routine iron intake decreases the risk of developing anemia in preterm infants.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The University of Texas Health Science Center, Houston
• Treatments: Iron; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

1. birth weight: < 1500 grams

2. Tolerating iron fortified preterm formula or fortified breast milk at 120cc/kg/day by 8 weeks of age

3. ≤32 weeks adjusted post-menstrual age at the time of enrollment

Exclusion Criteria:

1. cyanotic heart disease

2. bowel resection prior to enrollment